tafasitamab (Monjuvi) Report issue

Biologics mAb Orphan Drug FDA Approved FDA First in Class Fast Track FDA Breakthrough Therapy FDA Accelerated Approval FDA
AACT
Back

Drug Pricing Summary

VA FSS

$912.5600

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
tafasitamab 200 mg / 5 mL (5 mL INJECTION) $912.5600 VA FSS
  • MONJUVI (1)
    		•  MorphoSys US, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue